UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen receptor signaling and mutations in prostate cancer

Asian journal of andrology, 2010-09, Vol.12 (5), p.639-657

Koochekpour, Shahriar

2010

Volltextzugriff (PDF)

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer

Oncotarget, 2016-09, Vol.7 (39), p.64447-64470

2016

Volltextzugriff (PDF)

Androgen receptor splice variants and prostate cancer: From bench to bedside

Oncotarget, 2017-03, Vol.8 (11), p.18550-18576

2017

Volltextzugriff (PDF)

Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer

Asian journal of andrology, 2013-03, Vol.15 (2), p.212-213

Koochekpour, Shahriar

2013

Volltextzugriff (PDF)

Commentary on "Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)"

Asian journal of andrology, 2015-01, Vol.17 (1), p.160-160

Koochekpour, Shahriar

2015

Volltextzugriff (PDF)

Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth

Cell reports (Cambridge), 2014-09, Vol.8 (5), p.1461-1474

2014

Volltextzugriff (PDF)

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications

International journal of biological sciences, 2013-01, Vol.9 (7), p.728-742

2013

Volltextzugriff (PDF)

Aberrant DNA Methylation and Prostate Cancer

Current genomics, 2011-11, Vol.12 (7), p.486-505

2011

Volltextzugriff (PDF)

Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men

PloS one, 2013-09, Vol.8 (9), p.e74688-e74688

2013

Volltextzugriff (PDF)

Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues

PloS one, 2014-07, Vol.9 (7), p.e103204-e103204

2014

Volltextzugriff (PDF)

DNA methylome and the complexity, of discovering prostate cancer biomarkers

Asian journal of andrology, 2011-09, Vol.13 (5), p.661-662

Koochekpour, Shahriar

2011

Volltextzugriff (PDF)

Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review

Journal of robotic surgery, 2021-06, Vol.15 (3), p.321-333

2021

Volltextzugriff (PDF)

Characterization of fibroblast-free CWR-R1ca castration-recurrent prostate cancer cell line

The Prostate, 2016-09, Vol.76 (12), p.1067-1077

2016

Volltextzugriff (PDF)

Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis

Indian journal of urology, 2022-07, Vol.38 (3), p.220-226

2022

Volltextzugriff (PDF)

Socioeconomic factors that impact patient no-shows in the ambulatory urology clinic

Journal of public health, 2022-05, Vol.30 (5), p.1293-1299

2022

Volltextzugriff (PDF)

Androgen receptor mutations and polymorphisms in African American prostate cancer

International journal of biological sciences, 2014-01, Vol.10 (6), p.643-651

2014

Volltextzugriff (PDF)

BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer

PloS one, 2013-01, Vol.8 (1), p.e52993-e52993

2013

Volltextzugriff (PDF)

Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT

International journal of biological sciences, 2014-01, Vol.10 (8), p.834-845

2014

Volltextzugriff (PDF)

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression

Translational oncology, 2019-08, Vol.12 (8), p.1056-1071

2019

Volltextzugriff (PDF)

Glutamate, glutamate receptors, and downstream signaling pathways

International journal of biological sciences, 2013-01, Vol.9 (9), p.948-959

2013

Volltextzugriff (PDF)

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

PloS one, 2010-07, Vol.5 (7), p.e11475

2010

Volltextzugriff (PDF)

Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion

Molecular cancer, 2010-02, Vol.9 (1), p.30-30, Article 30

2010

Volltextzugriff (PDF)

Optimal Transactivation by Epstein-Barr Nuclear Antigen 1 Requires the UR1 and ATH1 Domains

Journal of Virology, 2009-05, Vol.83 (9), p.4227-4235

2009

Volltextzugriff (PDF)

The Mutationally Activated Met Receptor Mediates Motility and Metastasis

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (24), p.14417-14422

1998

Volltextzugriff (PDF)

Commentary on＂Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe （French West Indies）

亚洲男性学杂志：英文版, 2015 (1), p.160-160

Shahriar Koochekpour

2015

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(109)
Dissertationen
(1)

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Androgen receptor signaling and mutations in prostate cancer

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer

Androgen receptor splice variants and prostate cancer: From bench to bedside

Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer

Commentary on "Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies)"

Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications

Aberrant DNA Methylation and Prostate Cancer

Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men

Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues

DNA methylome and the complexity, of discovering prostate cancer biomarkers

Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review

Characterization of fibroblast-free CWR-R1ca castration-recurrent prostate cancer cell line

Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis

Socioeconomic factors that impact patient no-shows in the ambulatory urology clinic

Androgen receptor mutations and polymorphisms in African American prostate cancer

BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer

Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression

Glutamate, glutamate receptors, and downstream signaling pathways

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion

Optimal Transactivation by Epstein-Barr Nuclear Antigen 1 Requires the UR1 and ATH1 Domains

The Mutationally Activated Met Receptor Mediates Motility and Metastasis

Commentary on＂Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe （French West Indies）

Suchergebnisse filtern